Currently, there are 1.93B common shares owned by the public and among those 1.93B shares have been available to trade.
The company’s stock has a 5-day price change of -1.18% and -7.24% over the past three months. CSX shares are trading -1.52% year to date (YTD), with the 12-month market performance down to -8.18% lower. It has a 12-month low price of $31.43 and touched a high of $40.12 over the same period. CSX has an average intraday trading volume of 12.03 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.03%, -6.80%, and -6.66% respectively.
Institutional ownership of CSX Corp (NASDAQ: CSX) shares accounts for 75.38% of the company’s 1.93B shares outstanding.
It has a market capitalization of $61.29B and a beta (3y monthly) value of 1.22. The stock’s trailing 12-month PE ratio is 17.08, while the earnings-per-share (ttm) stands at $1.86. The company has a PEG of 2.32 and a Quick Ratio of 1.23 with the debt-to-equity ratio at 1.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.39% over the week and 1.66% over the month.
Analysts forecast that CSX Corp (CSX) will achieve an EPS of 0.43 for the current quarter, 0.44 for the next quarter and 1.98 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.39 while analysts give the company a high EPS estimate of 0.39. Comparatively, EPS for the current quarter was 0.45 a year ago. Earnings per share for the fiscal year are expected to decrease by -0.86%, and 7.67% over the next financial year. EPS should shrink at an annualized rate of 7.36% over the next five years, compared to 7.59% over the past 5-year period.
Looking at the support for the CSX, a number of firms have released research notes about the stock. Jefferies stated their Buy rating for the stock in a research note on January 10, 2025, with the firm’s price target at $37. TD Cowen coverage for the CSX Corp (CSX) stock in a research note released on October 17, 2024 offered a Hold rating with a price target of $35. Wells Fargo on their part issued Equal Weight rating on June 07, 2024.
